Richard Barry

2.0k total citations
38 papers, 1.4k citations indexed

About

Richard Barry is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Richard Barry has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Ophthalmology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Richard Barry's work include Retinal Diseases and Treatments (8 papers), Retinal Imaging and Analysis (8 papers) and Advanced Proteomics Techniques and Applications (6 papers). Richard Barry is often cited by papers focused on Retinal Diseases and Treatments (8 papers), Retinal Imaging and Analysis (8 papers) and Advanced Proteomics Techniques and Applications (6 papers). Richard Barry collaborates with scholars based in United States, Australia and United Kingdom. Richard Barry's co-authors include Richard Smith, Weijun Qian, Mikhail Soloviev, Ethan Johnson, Joshua Adkins, Mary Lipton, Bobbie‐Jo Webb‐Robertson, Stephen Callister, Yuehe Lin and Charles Timchalk and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Richard Barry

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Barry United States 19 804 441 213 148 134 38 1.4k
Kousik Kundu United States 20 879 1.1× 160 0.4× 231 1.1× 77 0.5× 53 0.4× 35 2.1k
William E. Haskins United States 21 735 0.9× 287 0.7× 280 1.3× 50 0.3× 26 0.2× 48 1.5k
Jingyun Li China 29 1.6k 2.0× 195 0.4× 131 0.6× 38 0.3× 32 0.2× 118 2.8k
Manyu Li China 23 942 1.2× 174 0.4× 64 0.3× 50 0.3× 27 0.2× 73 2.1k
Norbert W. Lutz France 20 630 0.8× 146 0.3× 144 0.7× 37 0.3× 270 2.0× 55 1.2k
Ye Cheng China 24 557 0.7× 129 0.3× 104 0.5× 53 0.4× 101 0.8× 105 1.7k
Eddie L. Chang United States 22 931 1.2× 90 0.2× 233 1.1× 132 0.9× 51 0.4× 67 2.0k
Lizhen Chen China 21 982 1.2× 23 0.1× 213 1.0× 61 0.4× 70 0.5× 61 1.8k
Takanori Murakami Japan 20 301 0.4× 161 0.4× 124 0.6× 60 0.4× 73 0.5× 71 1.3k
Makoto Ando Japan 24 653 0.8× 85 0.2× 127 0.6× 481 3.3× 64 0.5× 141 2.4k

Countries citing papers authored by Richard Barry

Since Specialization
Citations

This map shows the geographic impact of Richard Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Barry more than expected).

Fields of papers citing papers by Richard Barry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Barry. The network helps show where Richard Barry may publish in the future.

Co-authorship network of co-authors of Richard Barry

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Barry. A scholar is included among the top collaborators of Richard Barry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Barry. Richard Barry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teo, Kelvin Yi Chong, et al.. (2025). Progression of Loss of Vision From Centre‐Involving Macular Atrophy in Eyes Treated for nAMD. Clinical and Experimental Ophthalmology. 53(8). 925–935.
2.
Hunt, Adrian, Yohei Hashimoto, Stephanie Young, et al.. (2025). Outcomes After Switching to Faricimab in Neovascular Age‐Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry. Clinical and Experimental Ophthalmology. 53(9). 1156–1167. 1 indexed citations
3.
Sabeti, Faran, Joshua van Kleef, Corinne F. Carle, et al.. (2024). Comparing 2-dimensional macular pigment optical density with objective and subjective perimetry and visual acuity in age-related macular degeneration. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(8). 2449–2459.
4.
Sabeti, Faran, Joshua van Kleef, Corinne F. Carle, et al.. (2023). Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema. PLoS ONE. 18(6). e0287319–e0287319. 7 indexed citations
5.
Bhandari, S., David Squirrell, Vuong Nguyen, et al.. (2021). Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry. Eye. 36(3). 594–602. 6 indexed citations
6.
Sallam, Ahmed B., et al.. (2018). A Review of Antimicrobial Therapy for Infectious Uveitis of the Posterior Segment.. PubMed. 7(4). 140–155. 11 indexed citations
7.
Barry, Richard, et al.. (2017). A Retrospective Analysis of Adverse Events in Hyperbaric Oxygen Therapy (2012-2015): Lessons Learned From 1.5 Million Treatments. Advances in Skin & Wound Care. 30(3). 125–129. 26 indexed citations
8.
Liu, Guodong, Jun Wang, Richard Barry, et al.. (2008). Nanoparticle‐Based Electrochemical Immunosensor for the Detection of Phosphorylated Acetylcholinesterase: An Exposure Biomarker of Organophosphate Pesticides and Nerve Agents. Chemistry - A European Journal. 14(32). 9951–9959. 131 indexed citations
9.
10.
Barry, Richard, Mark Young, Kenneth M. Stedman, & Edward A. Dratz. (2006). Proteomic mapping of the hyperthermophilic and acidophilic archaeon Sulfolobus solfataricus P2. Electrophoresis. 27(14). 2970–2983. 24 indexed citations
11.
Paša‐Tolić, Ljiljana, Christophe Masselon, Richard Barry, Yufeng Shen, & Richard Smith. (2004). Proteomic Analyses using an Accurate Mass and time Tag Strategy. BioTechniques. 37(4). 621–639. 130 indexed citations
12.
Barry, Richard & Dimitri A. Ivanov. (2004). Microfluidics in biotechnology. Journal of Nanobiotechnology. 2(1). 2–2. 75 indexed citations
13.
Soloviev, Mikhail, Richard Barry, Elaine Scrivener, & Jonathan Terrett. (2003). Combinatorial peptidomics: a generic approach for protein expression profiling. Journal of Nanobiotechnology. 1(1). 4–4. 8 indexed citations
14.
Barry, Richard, et al.. (2003). Competitive Assay Formats for High-Throughput Affinity Arrays. SLAS DISCOVERY. 8(3). 257–263. 21 indexed citations
15.
Barry, Richard, Mohammad Tadayyon, & Irene C. Green. (2002). Reproducibility of targeted gene expression measurements in human islets of Langerhans. Biochemical and Biophysical Research Communications. 298(3). 350–356. 2 indexed citations
16.
Barry, Richard, et al.. (1998). In vivo acetylation identified at lysine 70 of human lens αA‐crystallin. Protein Science. 7(6). 1451–1457. 37 indexed citations
17.
Gerard, James, Allan D. Friedman, Richard Barry, M.J. Carney, & Leslie L. Barton. (1997). An Analysis of Morning Report at a Pediatric Hospital. Clinical Pediatrics. 36(10). 585–588. 10 indexed citations
18.
Barry, Richard, et al.. (1994). A modified Apt test: A new look at an old test. Pediatric Emergency Care. 10(3). 189–191. 5 indexed citations
19.
Smith, S. K. & Richard Barry. (1990). A comparison of three formulations of TAC (tetracaine, Adrenalin, cocaine) for anesthesia of minor lacerations in children. Pediatric Emergency Care. 6(4). 266–270. 25 indexed citations
20.
Gómez, Carmela, et al.. (1958). The proteins of multiple myeloma. I. - Electrophoretic comparison studies on the proteins of the serum and bone marrow in patients with multiple myeloma. Medicina-buenos Aires. 18. 205–220. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kousik Kundu Breakdown of academic impact, for papers by William E. Haskins Breakdown of academic impact, for papers by Jingyun Li Breakdown of academic impact, for papers by Manyu Li Breakdown of academic impact, for papers by Norbert W. Lutz Breakdown of academic impact, for papers by Ye Cheng Breakdown of academic impact, for papers by Eddie L. Chang Breakdown of academic impact, for papers by Lizhen Chen Breakdown of academic impact, for papers by Takanori Murakami Breakdown of academic impact, for papers by Makoto Ando
Rankless by CCL
2026